Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 7
1968 6
1969 6
1970 4
1971 6
1972 2
1973 4
1974 3
1975 8
1976 4
1977 5
1978 3
1979 9
1980 6
1981 4
1982 9
1983 5
1984 7
1985 4
1986 5
1987 7
1988 7
1989 17
1990 13
1991 10
1992 6
1993 12
1994 6
1995 8
1996 5
1997 8
1998 5
1999 14
2000 9
2001 11
2002 4
2003 9
2004 6
2005 3
2006 9
2007 7
2008 9
2009 7
2010 5
2011 6
2012 7
2013 5
2014 5
2015 5
2016 6
2017 2
2018 1
2019 1
2020 2
2021 1
2022 2
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

331 results

Results by year

Filters applied: . Clear all
Page 1
Fostemsavir and ethinyl estradiol drug interaction: Clinical recommendations for co-administration.
Nwokolo N, Post E, Mageau AS, Shah R, Magee M, Mannino F, Ackerman P, Clark A, Moore K. Nwokolo N, et al. HIV Med. 2023 May;24(5):580-587. doi: 10.1111/hiv.13442. Epub 2022 Nov 13. HIV Med. 2023. PMID: 36372442 Free article. Clinical Trial.
METHODS: Effect of temsavir (active moiety) on the pharmacokinetics of ethinyl estradiol (EE) and norethindrone (NET) was evaluated in an open-label, single-sequence, four-cycle, four-treatment study in 26 healthy female participants (study 206279, NCT0248088 …
METHODS: Effect of temsavir (active moiety) on the pharmacokinetics of ethinyl estradiol (EE) and norethindrone (NET) w …
Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome.
Legro RS, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Williams NI, Gnatuk CL, Estes SJ, Fleming J, Allison KC, Sarwer DB, Coutifaris C, Dokras A. Legro RS, et al. J Clin Endocrinol Metab. 2015 Nov;100(11):4048-58. doi: 10.1210/jc.2015-2778. Epub 2015 Sep 24. J Clin Endocrinol Metab. 2015. PMID: 26401593 Free PMC article. Clinical Trial.
INTERVENTION: Women were randomly assigned to receive either 16 weeks of 1) continuous oral contraceptive pills (OCPs) (ethinyl estradiol 20 mcg/1 mg norethindrone acetate) ("OCP"); 2) lifestyle modification consisting of caloric restriction with meal replace …
INTERVENTION: Women were randomly assigned to receive either 16 weeks of 1) continuous oral contraceptive pills (OCPs) (ethinyl es …
The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.
Hendrix CW, Jackson KA, Whitmore E, Guidos A, Kretzer R, Liss CM, Shah LP, Khoo KC, McLane J, Trapnell CB. Hendrix CW, et al. Clin Pharmacol Ther. 2004 May;75(5):464-75. doi: 10.1016/j.clpt.2004.01.003. Clin Pharmacol Ther. 2004. PMID: 15116059 Clinical Trial.
RESULTS: The addition of isotretinoin to the oral contraceptive regimen resulted in small and inconsistent, although statistically significant (P <.04), decreases in the concentrations of both ethinyl estradiol (9% decrease in area under the plasma concentration- …
RESULTS: The addition of isotretinoin to the oral contraceptive regimen resulted in small and inconsistent, although statistically significa …
One-pill-a-month contraceptive.
Greenblatt RB. Greenblatt RB. Fertil Steril. 1967 Mar-Apr;18(2):209-11. Fertil Steril. 1967. PMID: 4164103 Free article. Clinical Trial. No abstract available.
Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptive.
Archer DF, Nakajima ST, Sawyer AT, Wentworth J, Trupin S, Koltun WD, Gilbert RD, Ellman H. Archer DF, et al. Obstet Gynecol. 2013 Sep;122(3):601-7. doi: 10.1097/AOG.0b013e3182a1741c. Obstet Gynecol. 2013. PMID: 23921878 Clinical Trial.
METHODS: This open-label, uncontrolled, multicenter study used an ultra low-dose OCP (1.0 mg norethindrone acetate and 10 micrograms ethinyl E2). The OCP was administered in a regimen of 24 days of a 28-day cycle followed by 10 micrograms ethinyl E2 for 2 day …
METHODS: This open-label, uncontrolled, multicenter study used an ultra low-dose OCP (1.0 mg norethindrone acetate and 10 micrograms …
Pharmacokinetic interaction between ethinyl estradiol, norethindrone and darunavir with low-dose ritonavir in healthy women.
Sekar VJ, Lefebvre E, Guzman SS, Felicione E, De Pauw M, Vangeneugden T, Hoetelmans RM. Sekar VJ, et al. Antivir Ther. 2008;13(4):563-9. Antivir Ther. 2008. PMID: 18672535 Clinical Trial.
BACKGROUND: An open-label, randomized, crossover study was performed to investigate the effect of multiple doses of darunavir co-administered with low-dose ritonavir (DRV/r) on the steady-state pharmacokinetics of the oral contraceptives ethinyl estradiol (EE) and …
BACKGROUND: An open-label, randomized, crossover study was performed to investigate the effect of multiple doses of darunavir co-administere …
Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol.
Eldon MA, Underwood BA, Randinitis EJ, Sedman AJ. Eldon MA, et al. Neurology. 1998 Apr;50(4):1146-8. doi: 10.1212/wnl.50.4.1146. Neurology. 1998. PMID: 9566412 Clinical Trial.
The present study sought to confirm whether concurrent administration of gabapentin would alter the pharmacokinetics of norethindrone acetate (2.5 mg) and ethinyl estradiol (50 mcg) in healthy US women. A total of 13 women were enrolled for three menstrual cy …
The present study sought to confirm whether concurrent administration of gabapentin would alter the pharmacokinetics of norethindrone …
Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.
Trapnell CB, Donahue SR, Collins JM, Flockhart DA, Thacker D, Abernethy DR. Trapnell CB, et al. Clin Pharmacol Ther. 1998 Dec;64(6):597-602. doi: 10.1016/S0009-9236(98)90050-9. Clin Pharmacol Ther. 1998. PMID: 9871424 Clinical Trial.
An open-label crossover study was conducted to evaluate the effect of thalidomide on the plasma pharmacokinetics of ethinyl estradiol (INN, ethinyl estradiol) and norethindrone (INN, norethisterone) among 10 women who had undergone surgic …
An open-label crossover study was conducted to evaluate the effect of thalidomide on the plasma pharmacokinetics of ethinyl estrad …
Bioequivalence of two oral contraceptive drugs containing norethindrone and ethinyl estradiol.
Saperstein S, Edgren RA, Lee GJ, Jung D, Fratis A, Kushinsky S, Mroszczak E, Dorr A. Saperstein S, et al. Contraception. 1989 Nov;40(5):581-90. doi: 10.1016/0010-7824(89)90130-3. Contraception. 1989. PMID: 2612166 Clinical Trial.
Two oral contraceptive drugs, Formulation A and Formulation B, both of similar hormonal content, were compared with each other to determine if they were bioequivalent. Both drugs contain 1 mg of norethindrone (NET) and 0.035 mg of ethinyl estradiol (EE). Appl …
Two oral contraceptive drugs, Formulation A and Formulation B, both of similar hormonal content, were compared with each other to determine …
A contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol.
Ballagh SA, Mishell DR Jr, Lacarra M, Shoupe D, Jackanicz TM, Eggena P. Ballagh SA, et al. Contraception. 1994 Dec;50(6):517-33. doi: 10.1016/0010-7824(94)90011-6. Contraception. 1994. PMID: 7705095 Clinical Trial.
A core design contraceptive vaginal ring (CVR) releasing 650 mcg of norethindrone acetate (NA) and 10, 20, 30 or 65 mcg of ethinyl estradiol (EE) daily was developed and tested in 99 women. ...
A core design contraceptive vaginal ring (CVR) releasing 650 mcg of norethindrone acetate (NA) and 10, 20, 30 or 65 mcg of ethinyl …
331 results